Aquarius Surgical TechnologiesAQQRF EV-to-FCF is -39.84 as of Jul. 03, 2026. The stock has 4 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Aquarius Surgical Technologies ranks worse than 239234.21% on this metric.
The historical rank and industry rank for Aquarius Surgical Technologies's EV-to-FCF or its related term are showing as below:
AQQRF'
s EV-to-FCF Range Over the Past 10 Years
Min: -173.32 Med: -13.77 Max: 268.93
Current: -40.63
During the past 13 years, the highest EV-to-FCF of Aquarius Surgical Technologies was 268.93. The lowest was -173.32. And the median was -13.77.
AQQRF's EV-to-FCF is ranked worse than 100% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs AQQRF: -40.63
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aquarius Surgical Technologies's PE Ratio (TTM) for today is calculated as:
Aquarius Surgical Technologies's share price for today is $0.0042.
Aquarius Surgical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.028.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aquarius Surgical Technologies EV-to-FCF Related Terms
Aquarius Surgical Technologies EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aquarius Surgical Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aquarius Surgical Technologies EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Aquarius Surgical Technologies's EV-to-FCF falls into.
Aquarius Surgical Technologies's current Enterprise Value is $4.98 Mil.
Aquarius Surgical Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aquarius Surgical Technologies (AQQRF) has a EV-to-FCF of -39.84 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aquarius Surgical Technologies and its competitors. According to the industry distribution chart, Aquarius Surgical Technologies ranks #999999 out of 418 companies in the Medical Devices & Instruments industry.
Is Aquarius Surgical Technologies' EV-to-FCF too high?
Aquarius Surgical Technologies' current EV-to-FCF is -39.84. Based on the distribution chart, Aquarius Surgical Technologies ranks #999999 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Aquarius Surgical Technologies' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aquarius Surgical Technologies ranks #999999 out of 418 companies for EV-to-FCF. This places Aquarius Surgical Technologies in the lower half of its industry. The industry median EV-to-FCF is 23.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aquarius Surgical Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aquarius Surgical Technologies's current EV-to-FCF is -39.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current EV-to-FCF of -39.84. The current EV-to-FCF is -39.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current EV-to-FCF is -39.84 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aquarius Surgical Technologies Business Description
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQQRF has been successfully added to your 